Transformations in plasma metabolic profiles of patients with major depression disorder during treatment

Araque A, Castillo PE, Manzoni OJ, Tonini R (2017) Synaptic functions of endocannabinoid signaling in health and disease. Neuropharmacology 124:13–24. https://doi.org/10.1016/j.neuropharm.2017.06.017

Article  CAS  PubMed  PubMed Central  Google Scholar 

Augustin SM, Lovinger DM (2018) Functional relevance of endocannabinoid-dependent synaptic plasticity in the central nervous system. ACS Chem Neurosci 9:2146–2161. https://doi.org/10.1021/acschemneuro.7b00508

Article  CAS  PubMed  Google Scholar 

Bao H, Li H, Jia Y et al (2021) Ganoderic acid A exerted antidepressant-like action through FXR modulated NLRP3 inflammasome and synaptic activity. Biochem Pharmacol 188:114561. https://doi.org/10.1016/j.bcp.2021.114561

Article  CAS  PubMed  Google Scholar 

Basselin M, Ramadan E, Rapoport SI (2012) Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans. Brain Res Bull 87:154–171. https://doi.org/10.1016/j.brainresbull.2011.12.001

Article  CAS  PubMed  Google Scholar 

Bot M, Milaneschi Y, Al-Shehri T et al (2020) Metabolomics profile in depression: a pooled analysis of 230 metabolic markers in 5283 cases with depression and 10,145 controls. Biol Psychiatry 87:409–418. https://doi.org/10.1016/j.biopsych.2019.08.016

Article  CAS  PubMed  Google Scholar 

Brunt TM, Bossong MG (2022) The neuropharmacology of cannabinoid receptor ligands in central signaling pathways. Eur J Neurosci 55:909–921. https://doi.org/10.1111/ejn.14982

Article  CAS  PubMed  Google Scholar 

Calder PC (2017) Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans 45:1105–1115. https://doi.org/10.1042/BST20160474

Article  CAS  PubMed  Google Scholar 

Cao S, Anishkin A, Zinkevich NS et al (2018) Transient receptor potential vanilloid 4 (TRPV4) activation by arachidonic acid requires protein kinase A-mediated phosphorylation. J Biol Chem 293:5307–5322. https://doi.org/10.1074/jbc.M117.811075

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caspani G, Kennedy S, Foster JA, Swann J (2019) Gut microbial metabolites in depression: understanding the biochemical mechanisms. Microb Cell 6:454–481. https://doi.org/10.15698/mic2019.10.693

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chahl LA (2011) TRP channels and psychiatric disorders. In: Islam MS (ed) Transient receptor potential channels. Springer Netherlands, Dordrecht, pp 987–1009

Freitas HR, Isaac AR, Malcher-Lopes R et al (2018) Polyunsaturated fatty acids and endocannabinoids in health and disease. Nutr Neurosci 21:695–714. https://doi.org/10.1080/1028415X.2017.1347373

Article  CAS  PubMed  Google Scholar 

Gai Z, Visentin M, Gui T et al (2018) Effects of farnesoid X receptor activation on arachidonic acid metabolism, NF-kB signaling, and hepatic inflammation. Mol Pharmacol 94:802–811. https://doi.org/10.1124/mol.117.111047

Article  CAS  PubMed  Google Scholar 

GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet 388:1545–1602. https://doi.org/10.1016/S0140-6736(16)31678-6

Article  Google Scholar 

Gopaldas M, Zanderigo F, Zhan S et al (2019) Brain serotonin transporter binding, plasma arachidonic acid and depression severity: a positron emission tomography study of major depression. J Affect Disord 257:495–503. https://doi.org/10.1016/j.jad.2019.07.035

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gui S, Liu Y, Zhong X et al (2018) Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics. Neuropsychiatr Dis Treat 14:1451–1461. https://doi.org/10.2147/NDT.S164134

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanna VS, Hafez EAA (2018) Synopsis of arachidonic acid metabolism: a review. J Adv Res 11:23–32. https://doi.org/10.1016/j.jare.2018.03.005

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hussain G, Anwar H, Rasul A et al (2020) Lipids as biomarkers of brain disorders. Crit Rev Food Sci Nutr 60:351–374. https://doi.org/10.1080/10408398.2018.1529653

Article  CAS  PubMed  Google Scholar 

Layé S, Nadjar A, Joffre C, Bazinet RP (2018) Anti-inflammatory effects of Omega-3 fatty acids in the brain: physiological mechanisms and relevance to pharmacology. Pharmacol Rev 70:12–38. https://doi.org/10.1124/pr.117.014092

Article  CAS  PubMed  Google Scholar 

Liu X, Liu C, Tian J et al (2020) Plasma metabolomics of depressed patients and treatment with Xiaoyaosan based on mass spectrometry technique. J Ethnopharmacol 246:112219. https://doi.org/10.1016/j.jep.2019.112219

Article  CAS  PubMed  Google Scholar 

Lu S, Han Y, Chu H et al (2017) Characterizing serum metabolic alterations of Alzheimer’s disease and intervention of Shengmai-San by ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. Food Funct 8:1660–1671. https://doi.org/10.1039/c7fo00154a

Article  CAS  PubMed  Google Scholar 

Malhi GS, Mann JJ (2018) Depression. Lancet 392:2299–2312. https://doi.org/10.1016/S0140-6736(18)31948-2

Article  PubMed  Google Scholar 

Mocking RJT, Naviaux JC, Li K et al (2021) Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence. Transl Psychiatry 11:37. https://doi.org/10.1038/s41398-020-01182-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muller C, Morales P, Reggio PH (2018) Cannabinoid ligands targeting TRP channels. Front Mol Neurosci 11:487. https://doi.org/10.3389/fnmol.2018.00487

Article  CAS  PubMed  Google Scholar 

Murrough JW, Abdallah CG, Mathew SJ (2017) Targeting glutamate signalling in depression: progress and prospects. Nat Rev Drug Discov 16:472–486. https://doi.org/10.1038/nrd.2017.16

Article  CAS  PubMed  Google Scholar 

Nedic Erjavec G, Sagud M, Nikolac Perkovic M et al (2021) Depression: biological markers and treatment. Prog Neuropsychopharmacol Biol Psychiatry 105:110139. https://doi.org/10.1016/j.pnpbp.2020.110139

Article  CAS  PubMed  Google Scholar 

Pan J, Xia J, Deng F et al (2018) Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study. Transl Psychiatry 8:130. https://doi.org/10.1038/s41398-018-0183-x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poleszak E, Wośko S, Sławińska K et al (2018) Cannabinoids in depressive disorders. Life Sci 213:18–24. https://doi.org/10.1016/j.lfs.2018.09.058

Article  CAS  PubMed  Google Scholar 

Pu J, Liu Y, Zhang H et al (2021) An integrated meta-analysis of peripheral blood metabolites and biological functions in major depressive disorder. Mol Psychiatry 26:4265–4276. https://doi.org/10.1038/s41380-020-0645-4

Article  CAS  PubMed  Google Scholar 

Regulska M, Szuster-Głuszczak M, Trojan E et al (2021) The emerging role of the Double-Edged impact of arachidonic Acid- derived eicosanoids in the neuroinflammatory background of depression. Curr Neuropharmacol 19:278–293. https://doi.org/10.2174/1570159X18666200807144530

Comments (0)

No login
gif